Goldfinch Health

Goldfinch Health today released its 2026 Billion Pill Pledge Annual Report, showcasing continuous progress in curbing unnecessary post-surgical opioid prescriptions, improving patient recovery, and lowering addiction risk across the nation. The report hig

Opioid overdose prevention initiative, the Billion Pill Pledge program, earns honor as part of Recovery Month celebration Lincoln, NE - September 10, 2026 - The Nebraska Department of Health and Human Services (DHHS) has recognized Goldfinch Health with a

Goldfinch Health is proud to announce that it has been officially recognized as a nationally certified Recovery Friendly Workplace by the National Recovery Friendly Workplace Institute. This prestigious certification recognizes Goldfinch's dedication to f

Goldfinch Health, a leader in surgical optimization and recovery, today announced the launch of its updated Prepared for Surgery Tool Kit. This updated suite of resources is designed to bridge the gap between clinical care and the home environment, offeri

The United States is aging, but rural communities are reaching the "golden years" much faster than urban centers. According to the U.S. Census Bureau, the median age in rural counties is significantly higher than in urban ones. Approximately 1 in 5 rural

In the high-stakes world of construction, a physical injury is more than a medical setback-it is a direct threat to a family's financial stability. For the members of the Painters District Council 30 (PDC 30), getting back to work isn't just a goal; it's

The Billion Pill Pledge program, powered by Goldfinch Health, will deploy evidence-based opioid minimizing resources to hospitals and providers serving Craighead, Baxter, Phillips, and Pope Counties in Arkansas. Arkansas currently faces a critical public

Saint Mary's Regional Health System (Russellville, Arkansas) is proud to announce its participation in the Billion Pill Pledge program, launched in partnership with Goldfinch Health and made possible by Arkansas Opioid Recovery Partnership Settlement Fund

What if the drug we ran from was safer than the one we ran to? In the early 2000s, the "Coxib Crisis" sent shockwaves through medicine. The withdrawal of Vioxx (rofecoxib) created a cardiovascular ghost that haunted every remaining drug in its class. For